These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 34606316)

  • 1. Iron Deficiency, Anemia, and Iron Supplementation in Patients With Heart Failure: A Population-Level Study.
    Wahid M; Islam S; Sepehrvand N; Dover DC; McAlister FA; Kaul P; Ezekowitz JA
    Circ Heart Fail; 2024 Apr; 17(4):e011351. PubMed ID: 38572652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function.
    Macdougall IC; Ponikowski P; Stack AG; Wheeler DC; Anker SD; Butler J; Filippatos G; Göhring UM; Kirwan BA; Kumpeson V; Metra M; Rosano G; Ruschitzka F; van der Meer P; Wächter S; Jankowska EA
    Clin J Am Soc Nephrol; 2023 Sep; 18(9):1124-1134. PubMed ID: 37382961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial.
    Rosano G; Ponikowski P; Vitale C; Anker SD; Butler J; Fabien V; Filippatos G; Kirwan BA; Macdougall IC; Metra M; Ruschitzka F; Kumpeson V; Goehring UM; van der Meer P; Jankowska EA;
    Cardiovasc Diabetol; 2023 Aug; 22(1):215. PubMed ID: 37592272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IV ferric carboxymaltose (Injectafer) for iron deficiency in heart failure.
    Med Lett Drugs Ther; 2024 Feb; 66(1695):22-24. PubMed ID: 38294767
    [No Abstract]   [Full Text] [Related]  

  • 5. Ferric Carboxymaltose in Heart Failure with Iron Deficiency.
    Anker SD; Filippatos G; Anker MS
    N Engl J Med; 2023 Nov; 389(22):2109. PubMed ID: 38048198
    [No Abstract]   [Full Text] [Related]  

  • 6. Ferric Carboxymaltose in Heart Failure with Iron Deficiency.
    Eisenga MF
    N Engl J Med; 2023 Nov; 389(22):2108-9. PubMed ID: 38048197
    [No Abstract]   [Full Text] [Related]  

  • 7. Ferric Carboxymaltose in Heart Failure with Iron Deficiency.
    Payán-Pernía S; Pérez-Simón JA; García-Erce JA
    N Engl J Med; 2023 Nov; 389(22):2108. PubMed ID: 38048196
    [No Abstract]   [Full Text] [Related]  

  • 8. Ferric Carboxymaltose in Heart Failure with Iron Deficiency. Reply.
    Mentz RJ; Hernandez AF
    N Engl J Med; 2023 Nov; 389(22):2109-10. PubMed ID: 38048199
    [No Abstract]   [Full Text] [Related]  

  • 9. Brown pigmentation on skin post intravenous ferric carboxymaltose.
    Kwan YH; Oh CC
    J Dermatol; 2024 Jul; ():. PubMed ID: 38963313
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to R Kirwan et al.
    Ludwig DS; Lennerz BS; Mey JT
    Curr Dev Nutr; 2022 May; 6(5):nzac038. PubMed ID: 35669043
    [No Abstract]   [Full Text] [Related]  

  • 11. Anaemia in Heart Failure Patients, Associated with Angiotensin - Renin - Aldosterone System Altering Medications.
    Jonaitienė N; Ramantauskaitė G; Laukaitienė J
    Heart Views; 2021; 22(3):196-200. PubMed ID: 34760051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent and Emerging Therapies for Iron Deficiency in Anemia of CKD: A Review.
    Bazeley JW; Wish JB
    Am J Kidney Dis; 2022 Jun; 79(6):868-876. PubMed ID: 34758368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of in-hospital intravenous iron supplementation on red blood cell transfusions: experience from an Internal Medicine Unit.
    Bergamaschi G; Livraghi A; Aronico N; Barteselli C; Bonadeo E; Del Rio V; Gabba M; Gentile L; Mengoli C; Perotti C; Di Sabatino A
    Blood Transfus; 2021 Nov; 19(6):448-455. PubMed ID: 34739371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In patients with acute HF and iron deficiency, IV ferric carboxymaltose improved quality of life at 4 to 24 wk.
    Donato AA; Green J
    Ann Intern Med; 2021 Oct; 174(10):JC110. PubMed ID: 34606316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure.
    Ponikowski P; Kirwan BA; Anker SD; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Haboubi T; Keren A; Khintibidze I; Kragten H; Martinez FA; McDonagh T; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Jankowska EA
    Eur J Heart Fail; 2019 Dec; 21(12):1651-1658. PubMed ID: 31883356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y.
    DeFilippis EM; Van Spall HGC
    Ann Intern Med; 2021 Apr; 174(4):JC45. PubMed ID: 33819065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
    Ponikowski P; Kirwan BA; Anker SD; McDonagh T; Dorobantu M; Drozdz J; Fabien V; Filippatos G; Göhring UM; Keren A; Khintibidze I; Kragten H; Martinez FA; Metra M; Milicic D; Nicolau JC; Ohlsson M; Parkhomenko A; Pascual-Figal DA; Ruschitzka F; Sim D; Skouri H; van der Meer P; Lewis BS; Comin-Colet J; von Haehling S; Cohen-Solal A; Danchin N; Doehner W; Dargie HJ; Motro M; Butler J; Friede T; Jensen KH; Pocock S; Jankowska EA;
    Lancet; 2020 Dec; 396(10266):1895-1904. PubMed ID: 33197395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferric carboxymaltose: a review of its use in iron deficiency.
    Keating GM
    Drugs; 2015 Jan; 75(1):101-27. PubMed ID: 25428711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anaemia and iron deficiency in clinical practice:from cardiology to gastroenterology and beyond].
    Češka R
    Vnitr Lek; 2014 Dec; 60(12):1033-9. PubMed ID: 25692829
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.